Kazia Therapeutics

-$0.11 (-0.95%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.

About KZIA

Kazia Therapeutics Ltd. engages in the pharmaceutical drug research and development. Its pipeline includes two clinical-stage drug development candidates such as GDC-0084, and Cantrixil.

CEO
James Garner
Employees
—
Headquarters
Sydney, New South Wales (NSW)
Founded
1994

KZIA Key Statistics

Market Cap
152.83M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
39.60K
High Today
$11.90
Low Today
$11.16
Open Price
$11.90
Volume
25.98K
52 Week High
$15.85
52 Week Low
$5.55

KZIA Earnings

Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Oct 8, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure